Nova Eye Medical Stock Fundamentals
| EYE Stock | 0.15 0.01 7.14% |
Nova Eye Medical fundamentals help investors to digest information that contributes to Nova Eye's financial success or failures. It also enables traders to predict the movement of Nova Stock. The fundamental analysis module provides a way to measure Nova Eye's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nova Eye stock.
At this time, Nova Eye's Depreciation And Amortization is comparatively stable compared to the past year. Selling General Administrative is likely to gain to about 12.4 M in 2024, despite the fact that Operating Income is likely to grow to (3.6 M). Nova | Select Account or Indicator |
Nova Eye Medical Company Operating Margin Analysis
Nova Eye's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Nova Eye Operating Margin | (0.26) % |
Most of Nova Eye's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nova Eye Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Nova Eye Medical has an Operating Margin of -0.255%. This is 99.27% lower than that of the Health Care Equipment & Supplies sector and 99.35% lower than that of the Health Care industry. The operating margin for all Australia stocks is 95.37% lower than that of the firm.
Nova Eye Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nova Eye's current stock value. Our valuation model uses many indicators to compare Nova Eye value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nova Eye competition to find correlations between indicators driving Nova Eye's intrinsic value. More Info.Nova Eye Medical is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nova Eye's earnings, one of the primary drivers of an investment's value.Nova Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nova Eye's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nova Eye could also be used in its relative valuation, which is a method of valuing Nova Eye by comparing valuation metrics of similar companies.Nova Eye is currently under evaluation in operating margin category among its peers.
Nova Fundamentals
| Return On Equity | -0.39 | ||||
| Return On Asset | -0.19 | ||||
| Profit Margin | (0.38) % | ||||
| Operating Margin | (0.26) % | ||||
| Current Valuation | 30.41 M | ||||
| Shares Outstanding | 229.06 M | ||||
| Shares Owned By Insiders | 18.59 % | ||||
| Shares Owned By Institutions | 18.74 % | ||||
| Price To Book | 1.56 X | ||||
| Price To Sales | 1.52 X | ||||
| Revenue | 23.32 M | ||||
| Gross Profit | 14.39 M | ||||
| EBITDA | (5.98 M) | ||||
| Net Income | (8.79 M) | ||||
| Cash And Equivalents | 7.42 M | ||||
| Total Debt | 3.35 M | ||||
| Book Value Per Share | 0.09 X | ||||
| Cash Flow From Operations | (7.86 M) | ||||
| Earnings Per Share | (0.04) X | ||||
| Target Price | 0.59 | ||||
| Beta | 0.96 | ||||
| Market Capitalization | 35.54 M | ||||
| Total Asset | 29.88 M | ||||
| Retained Earnings | (30.69 M) | ||||
| Working Capital | 9.07 M | ||||
| Net Asset | 29.88 M |
About Nova Eye Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nova Eye Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Eye using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Eye Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | -734.9 K | -698.1 K | |
| Total Revenue | 23.3 M | 30.6 M | |
| Cost Of Revenue | 3.1 M | 3 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nova Stock Analysis
When running Nova Eye's price analysis, check to measure Nova Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Eye is operating at the current time. Most of Nova Eye's value examination focuses on studying past and present price action to predict the probability of Nova Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Eye's price. Additionally, you may evaluate how the addition of Nova Eye to your portfolios can decrease your overall portfolio volatility.